VentriPoint Diagnostics Ltd. (VPTDF) Changes the Way Doctors Look at Hearts
VentriPoint Diagnostics, a Seattle-based heart analysis technology company, is in the process of changing the way hearts are analyzed, a…
Blog
VIASPACE, Inc. (VSPC) and the World’s First Real Power Crop
Although the idea of using biomass materials to generate clean energy has been around for a long time, the approach…
SmallCapVoice Interviews Executive Chairman of Webxu, Inc. (WBXU)
SmallCapVoice.com, Inc. announced today that a new audio interview with Webxu, a media company that owns and operates a network…
Inovio Pharmaceuticals, Inc. (INO) Receives $3.5 Million Grant to Develop Mass Vaccination Device
Inovio Pharmaceuticals is revolutionizing the vaccine industry. Its SynCon vaccines are designed to provide universal protection against known as well…
Crossroads Systems, Inc. (CRDS) StrongBox Archive Solution Deployed by FotoKem
Crossroads Systems, a global provider of data archive solutions, today announced that FotoKem, one of the nation's leading post-production companies…
ZIOPHARM Oncology, Inc. (ZIOP) Announces Presentation of Preclinical Data Supporting DNA-Based IL-12 Therapy for Breast Cancer
Yesterday, cancer therapy-focused biopharmaceutical company ZIOPHARM Oncology announced the presentation of results from a study in a breast cancer murine…
Engage Mobility, Inc. (ENGA) to Introduce State-of-the-Art Visual Engagement System
Engage Mobility, a digital video and mobile marketing company, later this summer will launch a “first-of-its-kind” augmented reality mobile platform…
The Aristocrat Group Corp. (ASCC) to Revolutionize Distilled Spirits Market with “Defining Innovation”
The Aristocrat Group, a brands management company currently focusing most of its attention on the $5.5 billion vodka market, today…
Rafarma Pharmaceuticals, Inc. (RAFA) Engages QualityStocks Investor Relations Services
Rafarma Pharmaceuticals announced earlier today that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily…
VistaGen Therapeutics, Inc. (VSTA) Secures $36 Million to Accelerate Drug Rescue, Predictive Toxicology, and Drug Metabolism Programs
VistaGen Therapeutics, a biotechnology company with stem cell technology designed to improve the predictability of the drug development cycle and…